InvestorsHub Logo

OPT

Followers 18
Posts 1107
Boards Moderated 0
Alias Born 07/27/2011

OPT

Re: None

Friday, 12/28/2012 11:34:20 AM

Friday, December 28, 2012 11:34:20 AM

Post# of 158400
long way to go yet

"The results of Regen's study will provide the safety profile data required for filing an IND application for the product with the FDA. Regen intends to file an IND application in the fourth quarter of 2012 and conduct Phase I/II trials during 2013 and 2014."

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.